Low levels of serum testosterone in middle-aged men impact pathological features of prostate cancer.
Llukani E, Katz BF, Agalliu I, Lightfoot A, Yu SS, Kathrins M, Lee Z, Su YK, Monahan Agnew K, McGill A, Eun DD, Lee DI.
Llukani E, et al. Among authors: yu ss.
Prostate Int. 2017 Mar;5(1):17-23. doi: 10.1016/j.prnil.2016.12.003. Epub 2017 Jan 12.
Prostate Int. 2017.
PMID: 28352619
Free PMC article.